Form D · Biotechnology

Xenetic Biosciences, Inc.

Framingham, MA · CIK 0001534525

Offering snapshot reported Oct 13, 2022 · SEC filing

Reported sold
$489K
Offering amount: $489K
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Oct 12, 2022
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 13, 2022Initial$488,835No comparison1SEC filing
May 4, 2022Initial$866,250No comparison2SEC filing
Aug 3, 2021Initial$12,500,000No comparisonNot reportedSEC filing
Jul 18, 2019Initial$251,508No comparison3SEC filing
Mar 7, 2019Initial$3,485,250No comparison3SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-461635

Source: Form D, filed Oct 13, 2022. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Grigory Borisenko Director
James Callaway Director
Firdaus Dastoor Director
Jeffrey Eisenberg Director, Executive
Dmitry Genkin Director
Roman Knyazev Director
Roger Kornberg Director
Curtis Lockshin Executive
Adam Logal Director
James Parslow Executive
Alexey Vinogradov Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
945 Concord St.
Framingham, MA, 01701